PCI Pharma Services will add a total of 120 jobs to Leinster by increasing the headcount at facilities in Drogheda and Stamullen.
Pharmaceutical outsourcing provider PCI Pharma Services has revealed that it will create 120 jobs, split between two of its facilities in Louth and Meath.
PCI provides a broad suite of outsourced pharmaceutical services at all stages of the supply chain, from early-stage development to commercial packaging. It was founded in 2012 and is headquartered in Philadelphia in the US.
This jobs announcement comes on the back of the company launching a new contained packaging facility for the primary and secondary packaging of highly potent projects at its site in Drogheda, Co Louth. More than half of the new positions – 70, to be exact – will be based at this facility.
The remaining 50 roles will be created at the PCI facility in Stamullen, Co Meath. Both facilities came into PCI’s ownership after the US firm acquired Meath-based Millmount Healthcare in late 2017 for an undisclosed amount.
At the time, PCI lauded the fact that Millmount was licensed to support clinical trial medicines, which made it an ideal hub for its clinical trial services given its position in the EU, the importance of which has only been intensified by the UK’s planned departure from the single market.
With the addition of Millmount, PCI has 18 facilities spread across North America and Europe, and employs more than 3,200 associates.
Welcoming the announcement, IDA Ireland CEO Martin Shanahan said: “The availability of this range of clinical and pharmaceutical services will increase the attractiveness of Ireland as an international base for early-stage speciality biopharma companies.
“It is also proof that Ireland is viewed as an attractive location in Europe for global companies seeking to provide stability around the evolving Brexit situation. I congratulate president and CEO Bill Mitchell and his team, and wish them continued success with their operations here.”
Meanwhile, Minister for Business, Enterprise and Innovation Heather Humphreys, TD, expressed joy at the news, saying that it was a “great vote of confidence in what Ireland has to offer, especially in a regional location”.
She added: “It will provide additional facilities and services for our thriving pharmaceutical sector.”
